Maintenance Treatment of Major Depression in Old Age
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elderly patients with major depression, including those having a first episode, are at high risk for recurrence of depression, disability, and death. METHODS: We tested the efficacy of maintenance paroxetine and monthly interpersonal psychotherapy in patients 70 years of age or older who had depression (55 percent of whom were having a first episode) in a 2-by-2, randomized, double-blind, placebo-controlled trial. Among patients with a response to treatment with paroxetine and psychotherapy, 116 were randomly assigned to one of four maintenance-treatment programs (either paroxetine or placebo combined with either monthly psychotherapy or clinical-management sessions) for two years or until the recurrence of major depression. Clinical-management sessions, conducted by the same nurses, social workers, and psychologists who provided psychotherapy, involved discussion of symptoms. RESULTS: Major depression recurred within two years in 35 percent of the patients receiving paroxetine and psychotherapy, 37 percent of those receiving paroxetine and clinical-management sessions, 68 percent of those receiving placebo and psychotherapy, and 58 percent of those receiving placebo and clinical-management sessions (P=0.02). After adjustment for the effect of psychotherapy, the relative risk of recurrence among those receiving placebo was 2.4 times (95 percent confidence interval, 1.4 to 4.2) that among those receiving paroxetine. The number of patients needed to be treated with paroxetine to prevent one recurrence was 4 (95 percent confidence interval, 2.3 to 10.9). Patients with fewer and less severe coexisting medical conditions (such as hypertension or cardiac disease) received greater benefit from paroxetine (P=0.03 for the interaction between treatment with paroxetine and baseline severity of medical illness). CONCLUSIONS: Patients 70 years of age or older with major depression who had a response to initial treatment with paroxetine and psychotherapy were less likely to have recurrent depression if they received two years of maintenance therapy with paroxetine. Monthly maintenance psychotherapy did not prevent recurrent depression. (ClinicalTrials.gov number, NCT00178100.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Second, we utilized a dual-criterion threshold for determining clinical relapse (SCID and HRSD); while commonly used (Klein et al., 2004, Reynolds et al., 2006), this approach prioritizes confidence in relapse events at the expense of excluding partial relapse phenomena.”
From Static and treatment-responsive brain biomarkers of depression relapse vulnerability following prophylactic psychotherapy: Evidence from a randomized control trial (2022) · cites this paper as Reynolds et al., 2006
In the citing paper
“These failed trials involved antidepressants such as tricyclic antidepressants (Maj et al., 1992), SSRIs (Wilson et al., 2003; Reynolds et al., 2006), the anxiolytic SNRI milnacipran (Rouillon et al., 2000), and a preparation of the plant Hypericum perforatum (St. John’s Wort; Kasper et al., 2008).”
From Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2016) · cites this paper as Reynolds et al., 2006
In the citing paper
“Late-life depression (LLD) is a common and debilitating condition, with less frequent remission and more frequent recurrence following first-line antidepressant treatment compared to depression experienced earlier in life1–7.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [2]
In the citing paper
“Continuing antidepressant medication in those who have initially done well appears to be effective in preventing relapse during 6‐12 months of continuation therapy, and in preventing recurrence for up to three years during longer‐term maintenance treatment, with reported numbers needed to treat of about 4 219 .”
From Mental health care for older adults: recent advances and new directions in clinical practice and research (2022) · cites this paper as [219]
In the citing paper
“Antidepressants, psychotherapy, or a combination reduce the relapse and recurrence rates of late-life major depression137–139.”
From Mechanisms and treatment of late-life depression (2019) · cites this paper as [138]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234
Self-citationHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The brief symptom inventory: an introductory report.
Derogatis, L. R., & Melisaratos, N. (1983) · Psychological Medicine · doi:10.1017/s0033291700048017 · Cited by 6,650
Psychological Assessment Resources
Abidin, R. R. (1995) · Medical Entomology and Zoology · Cited by 3,147
Unützer, J., Katon, W., Callahan, C. M., Williams, Jr., Hunkeler, E., Harpole, L., Hoffing, M., Della Penna, R. D., Noël, P. H., Lin, E. H. B., et al. (2002) · JAMA · doi:10.1001/jama.288.22.2836 · Cited by 2,405
Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990
Self-citationStructured Clinical Interview for DSM-III-R Personality Disorders
First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (2012) · PsycTESTS Dataset · doi:10.1037/t07827-000 · Cited by 1,403
Interpersonal Psychotherapy Of Depression
Klerman, G. L. (1984) · Medical Entomology and Zoology · Cited by 1,315
Research works printed but not linked: 4
- Zis AP, 1980, Psychopharmacol Bull, 16, 47
- Wagner EF, 1992, J Psychother Pract Res, 22, 281
- 10.1097/00004850-199611020-00008 · DOI · Paper page
- Wilson K, 2001, Cochrane Database Syst Rev, 2, CD000561
Cited by
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
Self-citationMalhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
“Age and age of onset does not appear to be a consistent factor, but the degree of comorbid medical illness appears associated with a considerably greater relapse rate, which may be particularly applicable in the elderly (Iosifescu et al., 2004b; Reynolds et al., 2006).”
BackgroundMechanisms and treatment of late-life depression
Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592
Mental health treatment seeking among older adults with depression: The impact of stigma and race
Conner, K. O., Copeland, V. C., Grote, N. K., Koeske, G., Rosen, D., Reynolds, C. F., & Brown, C. (2010) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181cc0366 · Cited by 568
Self-citationKennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Interpersonal Psychotherapy for Depression: A Meta-Analysis
Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10101411 · Cited by 511
McCarron, R. M., Shapiro, B., Rawles, J., & Luo, J. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202105180 · Cited by 492
Reynolds, C. F., Jeste, D. V., Sachdev, P. S., & Blazer, D. G. (2022) · World Psychiatry · doi:10.1002/wps.20996 · Cited by 465
Self-citationLam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
“Patients with risk factors (Table 12) require longer term treatment for a minimum of 2 years and, for some, lifetime [Level 3] (Geddes et al., 2003; Hansen et al., 2008; Reynolds et al., 2006).”
BackgroundTaylor, W. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1402180 · Cited by 394
Alexopoulos, G. S., Reynolds, C. F., Bruce, M. L., Katz, I. R., Raue, P. J., Mulsant, B. H., Oslin, D. W., Ten Have, T., & The PROSPECT Group (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121779 · Cited by 368
“org treated with paroxetine and monthly psychotherapy (27).”
BackgroundSelf-citationSymptoms, Depression, and Quality of Life in Patients With Heart Failure
Bekelman, D. B., Havranek, E. P., Becker, D. M., Kutner, J. S., Peterson, P. N., Wittstein, I. S., Gottlieb, S. H., Yamashita, T. E., Fairclough, D. L., & Dy, S. M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.05.005 · Cited by 356
Bekelman, D. B., Rumsfeld, J. S., Havranek, E. P., Yamashita, T. E., Hutt, E., Gottlieb, S. H., Dy, S. M., & Kutner, J. S. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0931-y · Cited by 306
Symptom burden in heart failure: assessment, impact on outcomes, and management
Alpert, C. M., Smith, M. A., Hummel, S. L., & Hummel, E. K. (2017) · Heart Failure Reviews · doi:10.1007/s10741-016-9581-4 · Cited by 304
“side effect profile and low risk of complications of overdose, particularly in the elderly [136].”
Bockting, C. L., Hollon, S. D., Jarrett, R. B., Kuyken, W., & Dobson, K. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.02.003 · Cited by 295
Lenze, E. J., Mulsant, B. H., Blumberger, D. M., Karp, J. F., Newcomer, J. W., Anderson, S. J., Dew, M. A., Butters, M. A., Stack, J. A., Begley, A. E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00308-6 · Cited by 283
Self-citationInterpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis
Cuijpers, P., Donker, T., Weissman, M. M., Ravitz, P., & Cristea, I. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15091141 · Cited by 283
A review of empirically supported psychological therapies for mood disorders in adults
Hollon, S. D., & Ponniah, K. (2010) · Depression and Anxiety · doi:10.1002/da.20741 · Cited by 267
“(2006)([62]) Continuation cognitive therapy to prevent relapse/recurrence in MDD Jarrett et al.”
BackgroundDepression and Cardiovascular Disease: Healing the Broken-Hearted
Whooley, M. A. (2006) · JAMA · doi:10.1001/jama.295.24.2874 · Cited by 251
Gartlehner, G., Gaynes, B. N., Hansen, R. A., Thieda, P., DeVeaugh-Geiss, A., Krebs, E. E., Moore, C. G., Morgan, L., & Lohr, K. N. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-10-200811180-00008 · Cited by 237
Nelson, J. C., Delucchi, K., & Schneider, L. S. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000308883.64832.ed · Cited by 230
Psychobiological factors of resilience and depression in late life
Laird, K. T., Krause, B., Funes, C., & Lavretsky, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0424-7 · Cited by 229
“Additional evidence for the role of inflammation in depression comes from studies indicating that (1) pro-inflammatory factors precede depressive symptom onset(191), (2) antidepressant treatments reduce pro-inflammatory factors(192), and (3) anti-cytokine therapy”
BackgroundUnützer, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp073754 · Cited by 222
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
Szymkowicz, S. M., Gerlach, A. R., Homiack, D., & Taylor, W. D. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02464-9 · Cited by 196
“If pharmacotherapy or neuromodulation stops, the risk of recurrence can be high [18, 250, 253].”
BackgroundBauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
“…implanted The SSRIs were also studied as alternatives to nortriptyline in the maintenance treatment of recurrent depression in older adults (Reynolds et al. 2001, 2006; Klysner et al. 2002; Gorwood et al. 2007) and showed superiority in preventing recurrence in comparison to placebo (for…”
BackgroundAndreescu, C., Lenze, E. J., Dew, M. A., Begley, A. E., Mulsant, B. H., Dombrovski, A. Y., Pollock, B. G., Stack, J., Miller, M. D., & Reynolds, C. F. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.027169 · Cited by 196
Self-citationIncidence and Recurrence of Late-Life Depression
Luijendijk, H. J., van den Berg, J. F., Dekker, M. J. H. J., van Tuijl, H. R., Otte, W., Smit, F., Hofman, A., Stricker, B. H. C., & Tiemeier, H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.12.1394 · Cited by 193
Karyotaki, E., Smit, Y., Holdt Henningsen, K., Huibers, M. J. H., Robays, J., de Beurs, D., & Cuijpers, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.036 · Cited by 189
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches
Peciña, M., Karp, J. F., Mathew, S., Todtenkopf, M. S., Ehrich, E. W., & Zubieta, J.-K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0117-2 · Cited by 190
Self-citationAizenstein, H. J., Butters, M. A., Wu, M., Mazurkewicz, L. M., Stenger, V. A., Gianaros, P. J., Becker, J. T., Reynolds, C. F., & Carter, C. S. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31817b60af · Cited by 187
Self-citationLavretsky, H., Reinlieb, M., St. Cyr, N., Siddarth, P., Ercoli, L. M., & Senturk, D. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14070889 · Cited by 184
Preventing Depression in Age-Related Macular Degeneration
Rovner, B. W., Casten, R. J., Hegel, M. T., Leiby, B. E., & Tasman, W. S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.8.886 · Cited by 175
Gallo, J. J., Morales, K. H., Bogner, H. R., Raue, P. J., Zee, J., Bruce, M. L., & Reynolds, C. F. (2013) · BMJ · doi:10.1136/bmj.f2570 · Cited by 172
Self-citationHansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1121 · Cited by 172
Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171
“As in our previous maintenance therapy trials 31, 32, recurrence of major depression was defined using SCID/DSM-IV criteria 22 , a Hamilton depression score (17-item) 23 of 15 or higher over two consecutive weeks, and confirmation by a geriatric psychiatrist not involved in the participant’s…”
Self-citationKok, R. M., Nolen, W. A., & Heeren, T. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.036 · Cited by 167
“Studies intomaintenance treatment (8 studies: Alexopoulos et al., 2000; Georgotas et al., 1989; Gorwood et al., 2007; Klysner et al., 2002; Old Age Depression Interest Group, 1993; Reynolds et al., 1999a, 1999b; Reynolds et al., 2006; Wilson et al., 2003) were also excluded.”
MethodRelapse and recurrence prevention in depression: Current research and future prospects
Beshai, S., Dobson, K. S., Bockting, C. L. H., & Quigley, L. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.09.003 · Cited by 165
“As Vittengl et al. (2007) point out, relapse/recurrence rates vary considerably across studies, and it is likely that a number of moderators of these rates are involved. Recently, Bockting, Spinhoven, Koeter, Wouters, and Schene (2006) reported that risk factors for relapse/recurrence included a high number of previou…”
BackgroundInfluentialReynolds, C. F., Cuijpers, P., Patel, V., Cohen, A., Dias, A., Chowdhary, N., Okereke, O. I., Amanda Dew, M., Anderson, S. J., Mazumdar, S., et al. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124544 · Cited by 163
“An important caveat in this discussion, however, is demonstrated by data showing that SSRI pharmacotherapy is effective in the prevention of recurrent episode depression, an enormously important clinical issue in the care of older adults (38).”
Self-citationCognitive performance in suicidal depressed elderly: preliminary report
Dombrovski, A. Y., Butters, M. A., Reynolds, C. F., Houck, P. R., Clark, L., Mazumdar, S., & Szanto, K. (2008) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180f6338d · Cited by 159
Self-citationTwenty-Year Depressive Trajectories Among Older Women
Byers, A. L., Vittinghoff, E., Lui, L.-Y., Hoang, T., Blazer, D. G., Covinsky, K. E., Ensrud, K. E., Cauley, J. A., Hillier, T. A., Fredman, L., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.43 · Cited by 156
“Such maintenance treatment is also strongly supported by the maintenance trials from Pittsburgh and elsewhere.(42,43) In summary, investigation of combating symptom burden by improving physical function, managing cardiovascular conditions, and promoting positive lifestyle factors alone or in combination with antidepre…”
BackgroundResidual symptoms and recurrence during maintenance treatment of late-life depression
Dombrovski, A. Y., Mulsant, B. H., Houck, P. R., Mazumdar, S., Lenze, E. J., Andreescu, C., Cyranowski, J. M., & Reynolds, C. F. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.020 · Cited by 173
Self-citationWetherell, J. L., Petkus, A. J., White, K. S., Nguyen, H., Kornblith, S., Andreescu, C., Zisook, S., & Lenze, E. J. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081104 · Cited by 151
Self-citationContinuation and maintenance treatments for depression in older people
Wilkinson, P., & Izmeth, Z. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006727.pub3 · Cited by 151
The relationship between age, anxiety, and depression in older adults with cancer
Wiesel, T. W., Nelson, C. J., Tew, W. P., Hardt, M. E., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Gajra, A., Lichtman, S. M., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3638 · Cited by 160
Gray Matter Changes in Late Life Depression—a Structural MRI Analysis
Andreescu, C., Butters, M. A., Begley, A. E., Rajji, T. K., Wu, M., MELTZER, C. C., Reynolds, C. F., & Aizenstein, H. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301655 · Cited by 153
“Details of the MTLD studies’ protocols are described elsewhere (Reynolds et al, 2006).”
MethodSelf-citationKok, R. M., Heeren, T. J., & Nolen, W. A. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ec8085 · Cited by 141
Default-mode network connectivity and white matter burden in late-life depression
Wu, M., Andreescu, C., Butters, M. A., Tamburo, R., Reynolds, C. F., & Aizenstein, H. (2011) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.04.003 · Cited by 140
“Details of the MTLD-II study protocol are described elsewhere (Reynolds et al., 2006).”
BackgroundMethodSelf-citationPrevention of depression in older age
Almeida, O. P. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.03.005 · Cited by 154
Late-life depression in the primary care setting: Challenges, collaborative care, and prevention
Hall, C. A., & Reynolds-III, C. F. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.05.026 · Cited by 130
Lakey, S. L., LaCroix, A. Z., Gray, S. L., Borson, S., Williams, C. D., Calhoun, D., Goveas, J. S., Smoller, J. W., Ockene, J. K., Masaki, K., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03940.x · Cited by 151
Barry, L. C., Allore, H. G., Guo, Z., Bruce, M. L., & Gill, T. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.17 · Cited by 130
Challenges in the Treatment of Major Depressive Disorder With Psychotic Features
Rothschild, A. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt046 · Cited by 154
Dew, M. A., Whyte, E. M., Lenze, E. J., Houck, P. R., Mulsant, B. H., Pollock, B. G., Stack, J. A., Bensasi, S., & Reynolds, C. F. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.892 · Cited by 124
Self-citationGuidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine · doi:10.1017/s0033291710000826 · Cited by 118
Blumberger, D. M., Mulsant, B. H., Fitzgerald, P. B., Rajji, T. K., Ravindran, A. V., Young, L. T., Levinson, A. J., & Daskalakis, Z. J. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.579163 · Cited by 118
Self-citationKeller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Clarke, K., Mayo-Wilson, E., Kenny, J., & Pilling, S. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.04.002 · Cited by 113
Conner, K. O., Lee, B., Mayers, V., Robinson, D., Reynolds, C. F., Albert, S., & Brown, C. (2010) · Journal of Aging Studies · doi:10.1016/j.jaging.2010.05.007 · Cited by 112
“…that the efficacy and effectiveness of both psychotherapy and psychopharmacology for late life depression have been successfully established (Administration on Aging, 2001; Blazer, 2003; Cole & Dendukuri, 2004; Reynolds et al., 2006; United States Department of Health and Human Services, 1999).”
BackgroundSelf-citationSuicídio entre pessoas idosas: revisão da literatura
Minayo, M. C. D. S., & Cavalcante, F. G. (2010) · Revista de Saúde Pública · doi:10.1590/s0034-89102010000400020 · Cited by 101
Predictors of treatment outcome in depression in later life: A systematic review and meta-analysis
Tunvirachaisakul, C., Gould, R. L., Coulson, M., Ward, E. V., Reynolds, G., Gathercole, R. L., Grocott, H., Supasitthumrong, T., Tunvirachaisakul, A., Kimona, K., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.10.008 · Cited by 129
Functional connectomics in depression: insights into therapies
Chai, Y., Sheline, Y. I., Oathes, D. J., Balderston, N. L., Rao, H., & Yu, M. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.05.006 · Cited by 120
(2009) · Elsevier eBooks · doi:10.1016/b978-0-7020-2993-6.00027-4 · Cited by 106
Tham, A., Jonsson, U., Andersson, G., Söderlund, A., Allard, P., & Bertilsson, G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.013 · Cited by 104
fMRI Correlates of White Matter Hyperintensities in Late-Life Depression
Aizenstein, H. J., Andreescu, C., Edelman, K. L., Cochran, J. L., Price, J., Butters, M. A., Karp, J., Patel, M., & Reynolds, C. F. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10060853 · Cited by 106
Self-citationA Systematic Approach to Pharmacotherapy for Geriatric Major Depression
Mulsant, B. H., Blumberger, D. M., Ismail, Z., Rabheru, K., & Rapoport, M. J. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.05.002 · Cited by 99
Self-citationAdverse Effects of Pharmacologic Treatments of Major Depression in Older Adults
Sobieraj, D. M., Martinez, B. K., Hernández, A. V., Coleman, C. I., Ross, J. S., Berg, K. M., Steffens, D. C., & Baker, W. L. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15966 · Cited by 110
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B., Brand, U., Fleischhacker, W., Goodwin, G., Grunze, H., Knapp, M., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98
Alexopoulos, G. S., Canuso, C. M., Gharabawi, G. M., Bossie, C. A., Greenspan, A. J., Turkoz, I., & Reynolds, C. F. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31813546f2 · Cited by 101
Self-citationAdapting Interpersonal Psychotherapy for Older Adults at Risk for Suicide
Heisel, M. J., Talbot, N. L., King, D. A., Tu, X. M., & Duberstein, P. R. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.03.010 · Cited by 96
Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options
Thase, M. E. (2006) · CNS Spectrums · doi:10.1017/s1092852900015212 · Cited by 93
“The second positive study of longer-term SSRI therapy in late life depression, by Reynolds and colleagues,(30) used a design similar to the Pittsburgh group's studies of imipramine/nortriptyline and monthly IPT(812) to evaluate the efficacy of maintenance treatment with the SSRI paroxetine, monthly IPT, or the combina…”
BackgroundMethodMedical Burden in Late-Life Bipolar and Major Depressive Disorders
Gildengers, A. G., Whyte, E. M., Drayer, R. A., Soreca, I., Fagiolini, A. M., Kilbourne, A. M., Houck, P. R., Reynolds, C. F., Frank, E., Kupfer, D. J., et al. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318157c5b1 · Cited by 102
Self-citationClinical practice recommendations for depression
Malhi, G. S., Adams, D., Porter, R., Wignall, A., Lampe, L., O’Connor, N., Paton, M., Newton, L. A., Walter, G., Taylor, A., et al. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01382.x · Cited by 96
Möller, H., Baldwin, D. S., Goodwin, G. M., Kasper, S. F., Okasha, A., Stein, D. J., Tandon, R., Versiani, M., & Pharmacopsychiatry, T. W. S. O. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-3002-1 · Cited by 103
Risk factors for non-adherence to antidepressant treatment in patients with mood disorders
Cuevas, C. D. L., Peñate, W., & Sanz, E. J. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1582-9 · Cited by 111
Escitalopram Prevents Relapse in Older Patients With Major Depressive Disorder
Gorwood, P. A. P. M., Weiller, E., Lemming, O. M., & Katona, C. (2007) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000240823.94522.4c · Cited by 94
Empirically Derived Decision Trees for the Treatment of Late-Life Depression
Andreescu, C., Mulsant, B. H., Houck, P. R., Whyte, E. M., Mazumdar, S., Dombrovski, A. Y., Pollock, B. G., & Reynolds, C. F. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07081340 · Cited by 82
“A second maintenance study (maintenance therapies in late-life depression 2) provided 183 subjects age 69 and over with either a single or recurrent nonpsychotic depressive episode (20).”
BackgroundSelf-citationWatson, L. C., Zimmerman, S., Cohen, L. W., & Dominik, R. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31819b891c · Cited by 80
Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis
Nelson, J. C., Delucchi, K. L., & Schneider, L. S. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070927 · Cited by 80
“The open-label acute phase of a maintenance treatment study is informative in this respect (24, 65).”
BackgroundNeuropharmacological classification of antidepressant agents based on their mechanisms of action
Fasipe, O. (2018) · Archives of Medicine and Health Sciences · doi:10.4103/amhs.amhs_7_18 · Cited by 80
“Disinhibition of the serotonergic pathway from brainstem to hypothalamus, which mediates aspects of appetite and eating behaviors, is responsible for the reduced appetite, nausea, and even weight loss associated with SSRIs administration.[7,8,14,15,17,18]”
BackgroundIncomplete response in late-life depression: getting to remission
Lenze, E. J., Sheffrin, M., Driscoll, H. C., Mulsant, B. H., Pollock, B. G., Amanda Dew, M., Lotrich, F., Devlin, B., Bies, R., & Reynolds III, C. F. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/jlenze · Cited by 79
“Although some studies have not supported a link between medical burden and treatment outcome,(58,59) our group found that greater medical burden predicted poorer acute outcome to antidepressant augmentation (primarily with bupropion or nortriptyline(40)) and poorer maintenance outcomes.(60) One reason may be that medi…”
ResultSelf-citationCognition in older adults with bipolar disorder versus major depressive disorder
Gildengers, A. G., Butters, M. A., Chisholm, D., Anderson, S. J., Begley, A., Holm, M., Rogers, J. C., Reynolds, C. F., & Mulsant, B. H. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00995.x · Cited by 75
“Even if it was possible, it would make the findings less generalizable to the broader group of older adults with mood disorders who require long-term pharmacotherapy (37).”
BackgroundSelf-citationCohen, A., Gilman, S. E., Houck, P. R., Szanto, K., & Reynolds, C. F. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-008-0436-8 · Cited by 77
“In the maintenance treatment for late-life depression (MTLD) trials [45, 46 ], participants who lived in middle- or high-income neighborhoods were significantly more likely to respond to treatment than residents of low-income neighborhoods (e.g., median household incomes 46 ].”
BackgroundSelf-citationGaboda, D., Lucas, J., Siegel, M., Kalay, E., & Crystal, S. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03322.x · Cited by 74
“Recent evidence indicates that 2 years of maintenance antidepressant therapy was associated with less risk of relapse for older adults with one or more episodes, although those with the greatest number and severity of concomitant medical illnesses received less preventive benefit.(28) The current study was not able to…”
BackgroundVariable selection for qualitative interactions
Gunter, L., Zhu, J., & Murphy, S. A. (2011) · Statistical Methodology · doi:10.1016/j.stamet.2009.05.003 · Cited by 77
“In clinical trials, a combination of predictive variable selection techniques and statistical testing of a small number of interaction variables suggested by expert opinion are most commonly used [5] [6] [7].”
BackgroundAssessment and treatment of major depression in older adults
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804766-8.00023-6 · Cited by 73
Self-citationAdapting interpersonal psychotherapy for older adults at risk for suicide: Preliminary findings
Heisel, M. J., Duberstein, P. R., Talbot, N. L., King, D. A., & Tu, X. M. (2009) · Professional Psychology: Research and Practice · doi:10.1037/a0014731 · Cited by 72
Antidepressant response trajectories and associated clinical prognostic factors among older adults
Smagula, S. F., Butters, M. A., Anderson, S. J., Lenze, E. J., Dew, M. A., Mulsant, B. H., Lotrich, F. E., Aizenstein, H., & Reynolds, C. F. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1324 · Cited by 71
“5-156) 104 (26-210) 80 (30-364) 104 (34-277) 104 (26.”
Self-citationTreatment-resistant Late-life Depression: Challenges and Perspectives
Knochel, C., Alves, G., Friedrichs, B., Schneider, B., Schmidt-Rechau, A., Wenzler, S., Schneider, A., Prvulovic, D., F. Carvalho, A., & Oertel-Knochel, V. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1305151013200032 · Cited by 69
“In combination with antidepressants, IPT has proven to significantly reduce symptoms of depression [82, 83].”
Trevizol, A. P., Goldberger, K. W., Mulsant, B. H., Rajji, T. K., Downar, J., Daskalakis, Z. J., & Blumberger, D. M. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5091 · Cited by 70
“latter of which may be more frequent and more serious than in their younger counterparts.(5,6)”
Self-citationMöller, H. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0689-8 · Cited by 73
Predictors of recurrence in remitted late-life depression
Deng, Y., McQuoid, D. R., Potter, G. G., Steffens, D. C., Albert, K., Riddle, M., Beyer, J. L., & Taylor, W. D. (2018) · Depression and Anxiety · doi:10.1002/da.22772 · Cited by 65
“Comorbid psychiatric symptoms, including sleep and anxiety symptoms predict recurrence (Andreescu et al., 2007; Reynolds et al., 2006), but not medical comorbidity or disability (Alexopoulos et al., 1989, 2000; Hinrichsen & Hernandez 1993; Reynolds et al., 2006).”
BackgroundResultInfluentialA Review of Brain Stimulation Treatments for Late-Life Depression
Blumberger, D. M., Hsu, J. H., & Daskalakis, Z. J. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0059-0 · Cited by 64
Szántó, K., Mulsant, B. H., Houck, P. R., Dew, M. A., Dombrovski, A. Y., Pollock, B. G., & Reynolds, C. F. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.015 · Cited by 65
“Patients were treated as in- and/or outpatients in three studies:Maintenance Therapies in Late-Life Depression1 and-2 (Reynolds et al., 2006); (MTLD-1 andMTLD-2) or Nortriptyline versus Paroxetine (NT/PX) (Mulsant et al., 2001).”
MethodSelf-citationDombrovski, A. Y., Lenze, E. J., Dew, M. A., Mulsant, B. H., Pollock, B. G., Houck, P. R., & Reynolds, C. F. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01292.x · Cited by 61
“No such benefit was evident for monthly psychotherapy.(7) The present analysis examined the long-term effects of treatment on quality of life, hypothesizing that paroxetine would be superior to placebo and interpersonal psychotherapy would be superior to clinical management, controlling for the effects of the other tr…”
BackgroundResultInfluentialSelf-citationKaneriya, S. H., Robbins-Welty, G. A., Smagula, S. F., Karp, J. F., Butters, M. A., Lenze, E. J., Mulsant, B. H., Blumberger, D., Anderson, S. J., Dew, M. A., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3447 · Cited by 59
Self-citation
Metadata
- Authors
- Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., Schlernitzauer, M. A., Whyte, E. M., Gildengers, A., Karp, J., Lenze, E., Szanto, K., Bensasi, S., & Kupfer, D. J.
- Affiliations
- University of Pittsburgh (US)
- Geriatric Research Education and Clinical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-03-16
- Volume
- 354
- Issue
- 11
- Pages
- 1130-1138
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2064397126
- Cited by
- 476
- References
- 43
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 16 · 2023: 18 · 2022: 11 · 2021: 9 · 2020: 11 · 2019: 27 · 2018: 17 · 2017: 19 · 2016: 16 · 2015: 27 · 2014: 19 · 2013: 22 · 2012: 29
- FWCI
- 33.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (K01MH001613, R01 MH37869, K01 MH 01613, P30MH052247, R37 MH43832, R37MH043832, K24 MH65416, K01MH001684, K24MH065416, P30MH071944, P30-MH52247, P30MH030915, P30-MH-30915, R01MH037869, K01MH01684)
- National Institute on Minority Health and Health Disparities (P60MD000207)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- major depressive disorder, older adults, maintenance therapy, paroxetine, interpersonal psychotherapy, depression recurrence, first-episode depression, comorbidities, antidepressant efficacy
- MeSH terms
- Aged, Combined Modality Therapy, Depressive Disorder, Major, Major Depressive Disorder, Double-Blind Method, Female, Humans, Male, Psychotherapy, Risk, Comorbidity, Selective Serotonin Reuptake Inhibitors, Paroxetine, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.